This file photo taken on March 28, 2024 shows a man walking past signage for Kobayashi Pharmaceutical outside of the company's office in Tokyo. - Japanese health supplement maker Kobayashi Pharmaceutical said on June 28, 2024 it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, or"beni koji", meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was probing five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.“Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact,” Kobayashi said in a statement.
Fermented with a mould culture, the ingredient has been used in food, alcoholic drinks and folk medicines for centuries around East Asia. Kobayashi Pharmaceutical had announced on March 22 that it was recalling three kinds of over-the-counter tablets containing beni koji.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: vanguardngrnews - 🏆 5. / 75 Read more »
Source: TheNationNews - 🏆 6. / 69 Read more »